As one of the most widely used and effective anticoagulant and antithrombotic drugs, heparin drugs occupy an important position in the antithrombotic medicine market. Qingdao Kowloon medicine production of low molecular weight heparin drugs is highly regarded by the market.

　　At present, heparin is the most effective drug in the treatment of thrombosis, especially deep venous thrombosis or thrombolysis pulmonary embolism. Heparin mainly includes ordinary heparin and low molecular weight heparin. In comparison, low molecular weight heparin preparation has better efficacy and safety.

　　Because ordinary heparin need to monitor part of the activation of thrombin time to prevent potential bleeding, then there will be some allergic reaction, thrombocytopenia, osteoporosis, etc., but low molecular heparin without monitoring of activation of thrombin time, greatly improving the clinical compliance, and greatly reduce the ordinary heparin in the process of long-term use of the adverse reactions.

　　In addition, the greatest safety risk of anticoagulation comes from the risk of bleeding, which is greatly reduced with LMWH compared with plain heparin. That's the advantage of low molecular weight heparin. Low molecular weight heparin preparation has higher safety and wide clinical application. Low molecular weight heparin preparation has become the mainstream of heparin preparation.